Showing 51–75 of 110 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Okumu Albert, Odeny Lazarus, Ochieng John Benjamin, Odhiambo Ben, Sitati Ruth, et al.
…tive, was significant a p < 0.001, hence adequate TB/HIV integration and management, use of molecular techniques, and accurate identification is critical.
Katherine Laycock, Karl-Günter Technau, Patricia Lelo, Watsamon Jantarabenjakul, Caroline Yonaba, et al.
…ONS:** Overall reported availability of NAAT and integrated TB/HIV treatment for CLHIV cared for at these IeDEA sites in LMICs is encouraging but varies by context. Heterogeneous implementation gaps remain-particularly for drug susceptibility testing, TPT delivery, and TPT regime…
Melat Hatiya, Yared Merid, Addis Mola, Fanuel Belayneh, Musa Mohammed Ali
…is among the 30 countries with the highest burden of TB and TB/HIV co-infection. The emergence and spread of drug-resistant TB present significant challenges to TB care and control efforts, particularly multi-drug-resistant TB, which poses a serious public health issue in low-inc…
Breli Bonheur Ngouama, Freisnel Hermeland Mouzinga, Mita Naomie Merveille Dello, Jean Claude Djontu, Darrel Ornelle Elion Assiana, et al.
…t to follow-up and a low treatment success in patients with TB/HIV and those who were MDR. The findings highlight the need to enhance supervision, improve directly observed treatment short course monitoring, and develop strategies to minimize patients lost to follow-up.
Susanna Caminada, Roberto Benoni, Maria Grazia Dente, Claudia Robbiati, Joaquim Tomas, et al.
…tidrug-resistant-TB (from 0.2% in 2018 to 2.1% in 2022) and TB/HIV co-infections (from 6% in 2018 to 8.8% in 2021). The impact was most pronounced in the province of Luanda (capital city). TB services in Angola were disproportionately affected compared to general healthcare acces…
World Health Organization
…ry strengthening and diagnostic technologies, collaborative TB/HIV activities, financing, and research and development of new diagnostics, drugs and vaccines. It identifies persistent gaps in case detection, treatment coverage and funding, while describing progress in the use of …
World Health Organization
…-TB), laboratory strengthening and diagnostic technologies, TB/HIV collaborative activities, financing, and research and development of new drugs, diagnostics and vaccines. Particular attention is given to the expansion of rapid molecular testing, persistent gaps in MDR-TB treatm…
World Health Organization
…development, as well as collaborative activities addressing TB/HIV and drug-resistant tuberculosis. It highlights substantial expansion of access to treatment since the mid-1990s, contributing to millions of lives saved, alongside persistent challenges such as missed cases, limit…
Jakubowiak, Wiesław, Korzeniewska-Koseła, Maria, Kuś, Jan, Michałowska-Mitczuk, Dorota, Wesołowski, Stefan, et al.
…ement of drug-resistant tuberculosis and the combination of TB/HIV. Finally, the management of tuberculosis in groups at risk and health education are discussed. It is expected that this manual will be of help to all NTPs which are changing their control strategies
European Centre for Disease Prevention and Control, World Health Organization. Regional Office for Europe
…spite the efforts made, the burden in relation to RR-TB and TB/HIV is still considerable, underlining the need to introduce more innovative and effective approaches to the diagnosis and treatment of TB and MDR-TB.
European Centre for Disease Prevention and Control, World Health Organization. Regional Office for Europe
…in challenges faced by the Region are drug-resistant TB and TB/HIV coinfection. While the Region has a relatively high rate of MDR-TB case detection (73%), treatment success among these cases falls below the target (55%), which leads to ongoing transmission. TB is strongly associ…
World Health Organization. Regional Office for Europe
…l alarmingly high rates of drug-resistant TB (DR-TB) and of TB/HIV coinfection continue to be of high public health concern. The European Region includes 9 of the 30 countries worldwide with the highest multidrug-resistant TB (MDRTB) burden. In 2016, an estimated near 20% of new …
Hargreaves, Sally, Rustage, Kieran, Nellums, Laura B, Powis, Jaynaide, Milburn, James, et al.
…n of tuberculosis (TB), multidrug-resistant TB (MDR-TB) and TB/HIV coinfection in some countries. This report examines evidence of effective and efficient service packages for the prevention, diagnosis and treatment of TB to inform strategies to address the TB burden in refugee a…
World Health Organization. Regional Office for Europe
…panied by a frightening rise in the incidence of MDR-TB and TB/HIV. The problem is compounded by inadequate political commitment, inadequate infrastructure, inadequate implementation of effective TB control strategies in many countries, and inadequate financial support. The Inter…
World Health Organization. Regional Office for Europe
…esponse to tuberculosis (TB), drug-resistant TB (DR-TB) and TB/HIV coinfection during the COVID-19 pandemic; 3) review and advise on plans for the development of a Roadmap on tuberculosis for the WHO European Region for 2023–2030 to reach the targets set out in the End TB Strateg…
World Health Organization. Regional Office for Europe
…) advise on prioritized actions to respond to TB, DR-TB and TB/HIV co-infection during the COVID-19 pandemic and beyond; (ii) review the progress made in implementing the recommendations of the 13th meeting of the TAG-TB; (iii) review the final report of the implementation of the…
World Health Organization. Regional Office for Europe
…panied by a frightening rise in the incidence of MDR-TB and TB/HIV. The problem is compounded by inadequate political commitment, inadequate infrastructure, inadequate implementation of effective TB control strategies in many countries, and inadequate financial support. The Inter…
Madaki S, Mohammed Y, Rogo LD, Yusuf M, Bala YG
…vention and management strategies, as most studies focus on TB/HIV co-infection. Methods A cross-sectional case study of age and gender was carried out in 140 individuals grouped into drug-resistant tuberculosis (DR-TB), drug-susceptible tuberculosis (DS-TB), and apparently healt…
World Health Organization. Regional Office for South-East Asia
…o strengthen TB control and prevent any further increase in TB/HIV and MDR-TB in the Region would not only be cost-effective but are essential to achieving the TB targets under the MDGs. "A Call to Stop TB in Asia" was endorsed by the Stop TB Coordinating Board at this meeting.
Davids LC, Crowley T
…l three World Health Organization (WHO) watch lists for TB, TB/HIV and MDR-TB, despite its significant contributions to policy. Method A policy review and content analysis were conducted of all publicly available SA and WHO drug-resistant TB policies developed between 2013 and 20…
Günther G, Saathoff E, Rachow A, Ekandjo H, Diergaardt A, et al.
…diagnostic performance of the GenID LPA in a high-incidence TB/HIV, real-world setting in Namibia. The LPA demonstrates only an acceptable diagnostic performance for Mtb and drug-resistance detection. The diagnostic sensitivity and specificity fall short of the WHO suggested targ…
Starshinova A, Belyaeva E, Doktorova N, Korotkevich I, Kudlay D
…s for TB, multidrug/rifampicin-resistant TB (MDR/RR-TB) and TB/HIV, 2021-2025, 2021). The study aimed to assess changes in epidemiological indicators of tuberculosis in the Russian Federation and to simulate these indicators in the post-COVID-19 period. Materials and methods The …
Yanagawa M, Morishita F, Oh KH, Rahevar K, Islam TA, et al.
…to 2019, 52 MDR/RR-TB cases were reported and there were 94 TB/HIV coinfected cases in 2015-2020. Treatment success was 74% in 2019 due to 18% of cases being unevaluated. In 2020, the estimated proportion of TB cases attributable to smoking, malnutrition, alcohol abuse and diabet…
Nyasulu PS, Hui DS, Mwaba P, Tamuzi JL, Sakala DY, et al.
…, with African countries having the highest rates of TB and TB/HIV co-infection. Its incidence rate among inmates is about 10 times higher than that of the general population. The growing prevalence of multidrug-resistant TB is particularly concerning, as it may affect high-risk …
McQuaid CF, Henrion MYR, Burke RM, MacPherson P, Nzawa-Soko R, et al.
…B reported to the World Health Organization for 45 high TB, TB/HIV and MDR-TB burden countries from 2013 to 2019. We compared trend predicted notifications to observed notifications in 2020 to estimate the number of people with TB likely to have missed or delayed diagnosis. We es…